Article
Molecular Basis and Genetic Modifiers of Thalassemia.
Hematology/oncology clinics of North America - 1 Apr 2018
Mettananda Sachith, Higgs Douglas R
Abstract excerpt
Thalassemia is a disorder of hemoglobin characterized by reduced or absent production of one of the globin chains in human red blood cells with relative excess of the other. Impaired synthesis of β-globin results in β-thalassemia, whereas defective synthesis of α-globin leads to α-thalassemia. Despite being a monogenic disorder, thalassemia exhibits remarkable clinical heterogeneity that is directly related to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
